Answers are grounded in this paper and cite their sources.
MicroRNAs regulate gene expression, but their roles in Alzheimer′s disease pathology and downstream molecular changes remain incompletely characterized. We integrated cortical small RNA-sequencing data from seven datasets across six postmortem cohorts comprising 1,738 individuals with transcriptomic, proteomic, genetic, and single-nucleus data. Meta-analysis of 405 microRNAs identified 16 associated with advanced and four with intermediate neurofibrillary tangle pathology, with miR-132-3p significant in both comparisons. Five microRNAs (miR-132-3p, miR-212-3p, miR-212-5p, miR-146b-5p, miR-3200-3p) showed evidence of mediating associations between target mRNA and protein expression and tau pathology. Consensus co-expression network analysis linked the miR-132/212 family to opposing neuronal/synaptic and oligodendrocyte/myelination-related programmes. Mediated targets were enriched among tau-associated differentially expressed genes across glial cell types, particularly astrocytes. Inferred cell-type regulatory networks further highlighted miR-132-3p and miR-146b as recurrent hubs. These findings prioritize a restricted set of cortical microRNAs and associated neuronal and glial molecular programmes for mechanistic investigation in Alzheimer′s disease.
No takes yet. Share an insight, caveat, or question.
Pishva et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: